Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: The Efficacy and Safety of Benmelstobart for GC/EGC [NA]

View source ↗

Summary

Clinical trial update indicates that Benmelstobart is being studied for gastric cancer and early gastric cancer, with the trial currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benmelstobart

Snippet

Sponsor: Xijing Hospital | Conditions: Gastric Cancer | NA | Status: NOT_YET_RECRUITING